COLGATE PALMOLIVE CO (CL): 10-Q filed October 30, 2026

AI analysis of the 10-Q that COLGATE PALMOLIVE CO filed with the U.S. SEC on October 30, 2026, grounded in the primary-source EDGAR filing.

Major restructuring underway with material earnings impact: Strategic Growth and Productivity Program launched with quantified charges spanning multiple geographies and business segments, creating near-term margin pressure and execution risk that could affect quarterly results

Acquisition integration remains ongoing concern: CareTOP Co Pty Ltd acquisition (April 2025) still integrating 17 months post-close, indicating slower-than-expected synergy realization and potential goodwill impairment risk if performance targets aren't met

Significant FX exposure presents structural headwind: Two-thirds (66.67%) of consolidated net sales derived internationally, creating substantial currency translation risk in current volatile environment that could materially impact reported earnings regardless of operational performance

Management tone notably neutral: Absence of forward-looking narrative or qualitative commentary suggests cautious/conservative management posture, potentially signaling uncertainty about near-term outlook amid restructuring and integration activities

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does COLGATE PALMOLIVE CO (CL)'s 10-Q filed October 30, 2026 say?

Quarterly Financial Results for Q3 2026 – Contains consolidated financial statements for the nine-month period ended September 30, 2026, and the three-month quarter ended September 30, 2026, compared to prior year periods (2025) Balance Sheet and Equity Information – Reports assets, liabilities, and stockholders' equity as of September 30, 2026, with comparative data from December 31, 2025,…

Is CL's 10-Q bullish or bearish?

Our analysis rates this filing BEARISH. The HIGH concern level (7.0/10) reflects a convergence of material negative signals: (1) Three new significant risks with two rated at severity 7-8/10, (2) A quantified restructuring program creating concrete near-term earnings pressure, (3) Structural FX…

How concerning is CL's latest 10-Q?

Concern level: HIGH (7.0/10). Key factors: Three new high-severity risks identified with average severity 6.7/10, including two risks rated 7-8/10; Strategic Growth and Productivity Program represents material restructuring with quantified cost exposure across multiple geographies and business segments - concrete near-term earnings headwind; 66.67% of consolidated net sales exposed to foreign…

What are the main risks flagged in CL's 10-Q?

Notable risk changes: Strategic Growth and Productivity Program initiated with quantified restructuring charges across multiple geographies and business segments - represents material near-term earnings headwind and execution risk; CareTOP Co Pty Ltd acquisition (April 2025) still in integration phase 17 months post-close, creating ongoing integration risk and potential goodwill impairment exposure if synergies…

What is the 30-day stock outlook for CL after this filing?

The model predicts CL will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.

About this analysis

Primary source:
View this 10-Q on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
October 30, 2026
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.